A Glance on Zika Virus Infection

Authors

  • Patil Priyanka A  Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, India School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajastan, India
  • Dr. Magdum C. S.  Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, India School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajastan, India
  • Dr. Singh S. K.  Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, India School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajastan, India

Keywords:

Zika Virus, Treatment, ZIKA.

Abstract

Zika virus is mainly transmitted through its vector Aedes aegyti are now a days affecting the world population, this infection has also affected to the pregnant women, which causes microcephaly in their newborns. Zika virus infection also causes Guillain Barre syndrome GBS. Till date, there was no specific medication available for treatment of Zika virus infection. Some preventive measurements will be applicable. The Scientists are trying to investigate the vaccine which will be useful in future.

References

  1. Dick GW, Kitchen SF, Haddow AJ (1952) Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46: 509-520.GW DickSF KitchenAJ Haddow1952Zika virus. I. Isolations and serological specificity.Trans R Soc Trop Med Hyg46509520
  2. Dick GW, Kitchen SF, Haddow AJ. Zika virus.
  3. I. Isolations and serological specificity. TransR Soc Trop Med Hyg 1952; 46:509-520.
  4. Duffy MR, Chen TH, Hancock WT, et al. Zikavirus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360:2536-2543.
  5. WHO 2016 Zika virus, Fact sheet. Updated January 2016, WHO Media Centre. Accessed: 30 January 2016.
  6. Kuno G, Chang GJ (2007) Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 152: 687-696.G. KunoGJ Chang2007Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses.Arch Virol152687696
  7. Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG,? et al. The 3.8 A resolution cryo-EM structure of Zika virus. Science 2016; 5316:1-7.
  8. Mlakar J, Korva M, Tul N, Popovi? M, Poljsak-Prijatelj M, Mraz J, et al. Zika virus associated with microcephaly. N Engl J Med 2016; 374:951-958.
  9. Perera-Lecoin M, Meertens L, Carnec X, Amara A. Flavivirus entry receptors: An update. Viruses 2013; 6:69-88.
  10. Beasley DWC, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, et al. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 2005; 79:8339-8347.
  11. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, et al. Genetic characterization of zika virus strains: Geographic expansion of the asian lineage. PLoS Negl Trop Dis 2012; 6:e1477.
  12. Faye O, Freire CCM, Iamarino A, Faye O, de Oliveira JVC, Diallo M, et al. Molecular evolution of zika virus during its emergence in the 20th Century. PLoS Negl Trop Dis 2014; 8:e2636.
  13. Piorkowski G, Richard P, Baronti C, Gallian P, Charrel R, LeparcGoffart I, et al. Complete coding sequence of Zika virus from Martinique Outbreak in 2015. Genome Announc 2016; 2:e00500-514.
  14. Calvet G, Aguiar RS, Melo AS, Sampaio SA, de Filippis I, Fabri A, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16:653-660.
  15. Driggers RW, Ho C-Y, Korhonen EM, Kuivanen S, J??skel?inen AJ, Smura T, et al. Zika Virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016; 374: 2142-2151.
  16. Garcez PP, Correia Loiola E, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 2016; 352:816-818.
  17. Venturi G, Zammarchi L and Fortuna C; An autochthonous case of Zika due to possible sexual transmission. Euro Surveill 2016: 21: 3014 - 3018.
  18. Hills SL, Russell K and Hennessey M; Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission?continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 215-216.
  19. Lanciotti RS, Kosoy OL and Laven JJ; Genetic and serologic properties of Zika virus associated with an epidemic. Emerg Infect Dis 2008; 14:1232-1239.
  20. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects?Reviewing the Evidence for Causality. N Engl J Med. 2016; 374(20):1981?7. Epub 2016/04/14. doi: 10.1056/ NEJMsr1604338 PMID: 27074377.
  21. Jamuar, SS; Walsh, CA (June 2015). "Genomic variants and variations in malformations of cortical development.". Pediatric clinics of North America. 62 (3): 571-85.
  22. Calvet G, Aguiar RS, Melo AS, Sampaio SA, de Filippis I, Fabri A, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16:653-660.
  23. World Health Organization (WHO). Assessment of infants with microcephaly in the context of Zika virus. 2016. p. 1-2. [Internet]; Available from: http://apps.who.int/iris/bitstream/10665/204475/1/WHO_ZIKV_MOC_16.3_eng.pdf?ua=1
  24. Freitas BP, Dias JRO, Prazeres J, Sacramento GA, Ko AI, Maia M, et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol 2016; 134:529-535.
  25. Ventura CV, Maia M, Ventura BV, Van Der Linden V, Ara?jo EB, Ramos RC, et al. Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection. Arq Bras Oftalmol 2016; 79:1-3.
  26. Leis AA, Stokic DS. Neuromuscular Manifestations of West Nile Virus Infection. Front Neurol 2012; 3:1-10.
  27. Lebrun G, Chadda K, Reboux AH, Martinet O, Gauzere BA. Guillain-Barr? syndrome after chikungunya infection. Emerg Infect Dis 2009; 15:495-496.
  28. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, et al. Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill 2014; 19:7-9.
  29. Nyati KK, Prasad KN. Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barr? syndrome. Mediators Inflamm 2014; 2014:1-10. Article ID 758639.
  30. Koga M, Gilbert M, Li J, Yuki N. Complex of GM1- and GD1alike lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies. PLoS One 2015; 10:e0124004.
  31. Alera, M. T. et al. Zika virus infection, Philippines, 2012. Emerg. Infect. Dis. 21, 722-724 (2015).
  32. Calvet, G. A. et al. First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil. J. Clin. Virol. 74, 1-3 (2016).
  33. Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M. & Rousset, D.Zika virus genome from the Americas. Lancet 387, 227-228 (2016).
  34. Kelser, E. A. Meet dengue's cousin, Zika. Microbes Infect. 18, 163-166 (2015).
  35. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232-1239 (2008).
  36. Centers for Disease Control and Prevention, Division of Vector-Borne Diseases. Memorandum: Updated diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories (2016).?
  37. Fauci, A. S. & Morens, D. M. Zika virus in the Americas?yet another arbovirus threat. N. Engl. J. Med. 374, 601-604 (2016).
  38. Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536-2543 (2009)
  39. Vannice, K. S., Roehrig, J. T. & Hombach, J. Next generation dengue vaccines: a review of the preclinical development pipeline. Vaccine33, 7091-7099 (2015).
  40. Cumming-Bruce, N. Zika vaccine still years away, W.H.O. says. The New York Times 9 March 2016. www.nytimes.com/2016/03/10/world/americas/zika-vaccine-still--years-away-who-says.html?_r=0 (4 May 2016).
  41. Maurice, J. WHO reveals its shopping list for weapons against Zika. Lancet 387, 733 (2016).
  42. Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature doi:10.1038/nature18952.
  43. Schwartz, L. M., Halloran, M. E., Durbin, A. P. & Longini, I. M. The dengue vaccine pipeline: implications for the future of dengue control. Vaccine 33, 3293-3298 (2015).

International Journal of Scientific Research in Science and Technology

Downloads

Published

2017-10-31

Issue

Volume 3, Issue 7, September-October-2017

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Patil Priyanka A, Dr. Magdum C. S., Dr. Singh S. K., " A Glance on Zika Virus Infection, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 3, Issue 7, pp.146-152, September-October-2017.